GOSS Dividend: Gossamer Bio Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

GOSS Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	44	114	0	0	0	0
Revenue Growth (YoY)	-57.99%	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	36	36	38	45	44	48
Research & Development	161	138	135	170	170	160
Operating Expenses	197	174	173	218	216	210
Other Non Operating Income (Expenses)	12	14	15	1	0	0
Pretax Income	-158	-55	-179	-229	-234	-243
Income Tax Expense	-2	0	--	--	--	--
Net Income	-156	-56	-179	-229	-234	-243
Net Income Growth	117%	-69%	-22%	-2%	-4%	35%
Shares Outstanding (Diluted)	227.98	226.22	152.62	84.57	74.84	68.51
Shares Change (YoY)	1%	48%	80%	13%	9%	25%
EPS (Diluted)	-0.69	-0.24	-1.17	-2.71	-3.13	-3.55
EPS Growth	110%	-79%	-56.99%	-13%	-12%	8%
Free Cash Flow	-158	-3	-159	-187	-190	-177
Free Cash Flow Per Share	-0.69	-0.01	-1.04	-2.21	-2.53	-2.58
Gross Margin	--	--	--	--	--	--
Operating Margin	-347.72%	-51.75%	0%	0%	0%	0%
Profit Margin	-354.54%	-49.12%	0%	0%	0%	0%
Free Cash Flow Margin	-359.09%	-2.63%	0%	0%	0%	0%
EBITDA	-153	-59	-172	-217	-215	-209
EBITDA Margin	-347.72%	-51.75%	0%	0%	0%	0%
D&A For EBITDA	0	0	1	1	1	1
EBIT	-153	-59	-173	-218	-216	-210
EBIT Margin	-347.72%	-51.75%	0%	0%	0%	0%
Effective Tax Rate	1.26%	0%	--	--	--	--